These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1253708)

  • 41. A clinical study comparing the effect of small doses of heparin with the effects of carbocromen and pentaerythrityl tetranitrate in angina pectoris. Some questions of the therapeutical mechanism of heparin.
    Goldberg GA; Suriadnova BA; Stepanov MA; Kochanko EP
    Cor Vasa; 1972; 14(2):81-95. PubMed ID: 5050956
    [No Abstract]   [Full Text] [Related]  

  • 42. Cloricromene improves survival rate and peritoneal macrophage function in splanchnic artery occlusion shock in rats.
    Sturniolo R; Squadrito F; Altavilla D; Trimarchi GR; Prosdocimi M; Caputi AP
    Circ Shock; 1989 Jul; 28(3):267-77. PubMed ID: 2766481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
    Verdecchia P
    Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical evaluation of Intenkordin].
    Markiewicz M; Korolko A; Hruczkowska E
    Pol Tyg Lek; 1972 May; 27(21):796-8. PubMed ID: 5028365
    [No Abstract]   [Full Text] [Related]  

  • 46. [Myocardial infarct and the practitioner's emergency medical pouch: place of intensain].
    Mazuez J
    Therapeutique; 1970 Dec; 46(10):1049-52. PubMed ID: 5511934
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intensain for city patients].
    Casanova P
    Mars Med; 1968; 105(1):71-4. PubMed ID: 5743335
    [No Abstract]   [Full Text] [Related]  

  • 48. [Therapy of severe coronary insufficiency with Intensain].
    Friese G; Eisenbarth D
    Med Welt; 1968 Sep; 36():1896-904. PubMed ID: 5716633
    [No Abstract]   [Full Text] [Related]  

  • 49. [The anti-anginous action of FT-9].
    DAILHEU-GEOFFROY P; NATAF J
    Actual Cardiol Angeiol Int (Paris); 1961; 10():231-2. PubMed ID: 13719360
    [No Abstract]   [Full Text] [Related]  

  • 50. The anti-anginal effect of a new Hungarian long-acting nitroglycerin drug (Nitromint retard) in stable effort angina pectoris.
    Antalóczy Z; Kékes E; Medvegy M; Dénes F; Görgényi F
    Ther Hung; 1987; 35(1):8-13. PubMed ID: 3125624
    [No Abstract]   [Full Text] [Related]  

  • 51. [Research progress on effect of coumarins compounds in anti-tumor].
    Hao G; Wang ZG; Fu WY; Yang Y
    Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(18):2016-9. PubMed ID: 19160774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Anti-angina effect of amiodarone in therapy-resistant angina pectoris].
    Meyer BJ; Gschwend S; Marx B; Amann FW
    Schweiz Med Wochenschr; 1992 Jan; 122(3):70-2. PubMed ID: 1346342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Influence of Carbocromen on A-V-conduction and refractory period. Electrophysiological study with His-bundle-electrography in experimental animals (author's transl)].
    Djonlagić H; Diederich KW
    Arzneimittelforschung; 1981; 31(12):2072-4. PubMed ID: 7199301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of therapy with a association of nifedipine and atenolol in patients with systemic arterial hypertension and angina pectoris].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Nov; 73(44):3191-4. PubMed ID: 7145199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 8. Angina pectoris agents with effect on calcium metabolism].
    Lumholtz IB
    Sygeplejersken; 1980 Apr; 80(16):21. PubMed ID: 6902528
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 9. Angina pectoris agents with effect on calcium metabolism].
    Lumholtz IB
    Sygeplejersken; 1980 May; 80(18):29. PubMed ID: 6902540
    [No Abstract]   [Full Text] [Related]  

  • 57. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparison of the effects of diltiazem and isradipine in patients with chronic stable angina pectoris].
    Meluzín J; Lupínek Z; Novák M; Rotrekl P
    Vnitr Lek; 1989 Nov; 35(11):1062-71. PubMed ID: 2533763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Nuredal on angina pectoris.
    Ostör E
    Ther Hung; 1968; 16(3):121-2. PubMed ID: 5726084
    [No Abstract]   [Full Text] [Related]  

  • 60. [Sludge phenomenon, angina pectoris syndrome and possibilities of therapy].
    SCHULTHEISS E; KOVACS G; NEMETH B
    Ther Ggw; 1963 Apr; 102():474-86. PubMed ID: 13987199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.